Acknowledgements We thank the staff of Al-Sadr Teaching Hospital and Al-Amal Specialized Hospital for Communicable Diseases in Najaf governorate-Iraq for their help in collecting samples
Special Populations Requiring Monitoring : Elderly patients may be more susceptible to gastrointestinal side effects and dehydration Patients taking insulin or sulfonylureas require dose adjustments of these medications to prevent hypoglycemia Patients with cardiovascular disease should be monitored, though cardiovascular outcomes data are still emerging Patients with depression or suicidal ideation (particularly for Zepbound) require careful monitoring for worsening symptoms Pediatric patients : Safety and efficacy have not been established in patients under 18 years of age Regarding renal function, no dose adjustment is required for patients with renal impairment, including those with end-stage renal disease
Chlorogenic acid (CGA) inhibits mitochondrial leakage of the chaperone protein HSP60 by restoring LONP1 protein levels, thereby alleviating liver mitochondrial inflammatory damage [111]
Menopause treatments Menopause can bring significant changes in sleep, mood, metabolism, and overall well-being
Endothelial LRP1a potential target for the treatment of Alzheimers disease : theme: drug discovery, development and delivery in Alzheimers disease guest editor: davide brambilla
Storage Container
